文献速递外周动脉疾病

门诊环境下顺行股浅动脉入路治疗下肢动脉疾病安全有效

Antegrade Superficial Femoral Artery Access for Lower Extremity Arterial Disease Is Safe and Effective in the Outpatient Setting.
PubMed 文献 · Ann Vasc Surg · 2020-11-30

回顾性分析2013至2018年门诊血管介入手术室718例下肢动脉介入患者,顺行股浅动脉入路448例(62.4%),逆行股总动脉入路270例。顺行组使用更小鞘管(4F为主,87.7% vs 69.5%),透视时间(9.5 vs 16.4 min)和造影剂用量(25.4 vs 38.5 mL)显著减少,技术成功率和并发症率无显著差异。

要点

  • 顺行股浅动脉入路在门诊环境下安全可行,可作为逆行股总动脉入路的有效替代。
  • 顺行入路显著减少透视时间和造影剂用量,且不增加并发症风险。
  • 顺行入路多使用4F鞘管,逆行入路多使用6F鞘管。

核心结论

  • 门诊环境下经皮顺行股浅动脉入路治疗下肢动脉疾病安全有效,较逆行股总动脉入路显著减少透视和造影剂使用。

研究设计与样本

  • 回顾性 review,纳入2013至2018年门诊血管介入手术室下肢动脉介入患者718例,排除需股总动脉入路的髂/股总/股深动脉血运重建206例及可能需大鞘的干预。

主要发现

  • 顺行股浅动脉入路448例(62.4%),逆行股总动脉入路270例。
  • 顺行组主要使用4F鞘管(87.7%),逆行组多数使用6F鞘管(69.5%),P<0.001。
  • 顺行组透视时间9.5 min,逆行组16.4 min,P<0.001;顺行组造影剂25.4 mL,逆行组38.5 mL,P<0.001。
  • 技术成功率顺行组93.2%,逆行组94.8%,P=0.42;总体并发症率顺行组2.7%,逆行组3.7%,P=0.78。
  • 入路部位并发症(1.1% vs 1.5%,P=0.94)、血肿(0.7% vs 1.1%,P=0.84)、假性动脉瘤(0.4% vs 0%,P=0.98)均无统计学差异。

临床怎么用

  • 在门诊血管介入手术室,对适合的患者可优先考虑顺行股浅动脉入路以降低辐射和造影剂负荷。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antegrade superficial femoral artery (SFA) access for peripheral artery disease reduces the time, radiation, and contrast required with contralateral common femoral access (CFA). Yet, this technique remains underutilized in the treatment of SFA, popliteal and tibial disease, and there remains limited data on the safety and effectiveness of antegrade SFA access in the outpatient setting. METHODS: A retrospective review of lower extremity peripheral arterial interventions in our office-based endovascular suite was conducted from 2013 to 2018. Interventions necessitating CFA access such as iliac, common femoral, or deep femoral artery revascularization were excluded (n = 206). In addition, interventions potentially requiring large sheaths not amenable to SFA access (e.g., popliteal aneurysm) were excluded. Relevant demographic and treatment variables including postoperative complications were abstracted. RESULTS: We identified 718 patients, who underwent revascularization of the SFA, popliteal and tibial arteries. Antegrade SFA access was chosen in 448 patients (62.4%) with the remaining 270 patients having retrograde CFA access. Antegrade SFA access was achieved primarily with a 4-French sheath, while a majority of retrograde CFA interventions utilized a 6-French sheath for access (87.7% vs 69.5%, P < 0.001). Significantly less fluoroscopy (9.5 vs 16.4 min, P < 0.001) and contrast (25.4 vs 38.5 mL, P < 0.001) were used during SFA access compared with retrograde access. Technical success was achieved in 93.2% with antegrade SFA vs 94.8% retrograde CFA access (P = 0.42). The overall rate of complications was low for both cohorts (2.7% vs 3.7%, P = 0.78) and there were no statistical differences in access site complications (1.1% vs 1.5%, P = 0.94), hematoma (0.7% vs 1.1%, P = 0.84), and pseudoaneurysm (0.4% vs 0%, P = 0.98) between techniques. CONCLUSIONS: Percutaneous antegrade SFA access can be performed safely in the outpatient setting and remains an effective alternative to retrograde CFA access with significantly less utilization of fluoroscopy and contrast.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Pezold M, Blumberg S, Sadek M, et al. Antegrade Superficial Femoral Artery Access for Lower Extremity Arterial Disease Is Safe and Effective in the Outpatient Setting. Ann Vasc Surg. 2020. PMID: 33271278. doi:10.1016/j.avsg.2020.10.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。